AstraZeneca PLC Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $0.95 | $0.96 | $0.96 |
| Q2 2024 | 1 | $0.98 | $0.98 | $0.98 |
| Q3 2024 | 4 | $0.99 | $1.06 | $1.02 |
| Q4 2024 | 1 | $1.01 | $1.01 | $1.01 |
| Q1 2025 | 2 | $1.14 | $1.14 | $1.14 |
| Q2 2025 | 2 | $1.14 | $1.14 | $1.14 |
| Q3 2025 | 2 | $1.20 | $1.20 | $1.20 |
| Q4 2025 | 2 | $1.11 | $1.11 | $1.11 |
AstraZeneca PLC Earnings Date And Information
AstraZeneca PLC last posted its earnings results on Thursday, July 25th, 2024. The company reported $0.99 earnings per share for the quarter, topping analysts' consensus estimates of $0.96 by $0.03. The company had revenue of 12.94 B for the quarter and had revenue of 45.81 B for the year. AstraZeneca PLC has generated $2 earnings per share over the last year ($1.91 diluted earnings per share) and currently has a price-to-earnings ratio of 31.14. AstraZeneca PLC has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
AstraZeneca PLC Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/25/2024 | Q2 2024 | $0.95 | $0.62 | -0.33 | $12.62 B | $12.94 B |
| 02/08/2024 | Q1 2024 | $0.74 | $0.70 | -0.04 | $12.68 B | |
| 02/20/2024 | Q4 2023 | $0.31 | $12.02 B | |||
| 11/09/2023 | Q3 2023 | $0.80 | $0.45 | -0.35 | $11.55 B | $11.49 B |
| 06/30/2023 | Q2 2023 | $0.59 | $11.01 B | $11.42 B | ||
| 03/31/2023 | Q1 2023 | $0.58 | $10.88 B | |||
| 02/21/2023 | Q4 2022 | $0.29 | $11.21 B | |||
| 09/29/2022 | Q3 2022 | $0.53 | $10.79 B | $10.98 B | ||
| 06/30/2022 | Q2 2022 | $0.12 | $10.45 B | $10.77 B | ||
| 03/30/2022 | Q1 2022 | $0.12 | $11.39 B | |||
| 02/22/2022 | Q4 2021 | -$0.11 | $12.01 B | |||
| 09/29/2021 | Q3 2021 | -$0.55 | $9.52 B | $9.87 B | ||
| 05/24/2021 | Q2 2021 | $0.21 | $7.44 B | $8.22 B | ||
| 02/11/2021 | Q1 2021 | $0.53 | $0.60 | 0.07 | $7.32 B | |
| 02/16/2021 | Q4 2020 | $0.39 | $7.41 B | |||
| 09/29/2020 | Q3 2020 | $0.25 | $6.61 B | $6.58 B | ||
| 07/31/2020 | Q2 2020 | $0.29 | $6.22 B | $6.28 B | ||
| 02/14/2020 | Q1 2020 | $0.53 | $0.30 | -0.23 | $6.35 B | |
| 10/24/2019 | Q4 2019 | $0.45 | $0.12 | -0.33 | $6.66 B | |
| 10/24/2019 | Q3 2019 | $0.45 | $0.12 | -0.33 | $6.13 B | $6.41 B |
AstraZeneca PLC Earnings: Frequently Asked Questions
-
When is AstraZeneca PLC's earnings date?
AstraZeneca PLC has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did AstraZeneca PLC beat their earnings estimates last quarter?
In the previous quarter, AstraZeneca PLC (:AZN) reported $0.99 earnings per share (EPS) to beat the analysts' consensus estimate of $0.96 by $0.03.
-
How can I listen to AstraZeneca PLC's earnings conference call?
The conference call for AstraZeneca PLC's latest earnings report can be listened to online.
-
How can I read AstraZeneca PLC's conference call transcript?
The conference call transcript for AstraZeneca PLC's latest earnings report can be read online.
-
How much revenue does AstraZeneca PLC generate each year?
AstraZeneca PLC (:AZN) has a recorded annual revenue of $45.81 B.
-
How much profit does AstraZeneca PLC generate each year?
AstraZeneca PLC (:AZN) has a recorded net income of $45.81 B. AstraZeneca PLC has generated $1.92 earnings per share over the last four quarters.
-
What is AstraZeneca PLC's price-to-earnings ratio?
AstraZeneca PLC (:AZN) has a price-to-earnings ratio of 31.14 and price/earnings-to-growth ratio is 21.28.
